Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN -0.38%74 Return-on-Tangible-Equity is 13.48% as of Dec. 2025, which is 12% above its 10-year median of 12.08. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.27 (Fairly Valued). Among 760 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 71.58% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. IVF hartmann Holding AG's annualized net income for the quarter that ended in Dec. 2025 was CHF20.1 Mil. IVF hartmann Holding AG's average shareholder tangible equity for the quarter that ended in Dec. 2025 was CHF149.2 Mil. Therefore, IVF hartmann Holding AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 13.48%.
The historical rank and industry rank for IVF hartmann Holding AG's Return-on-Tangible-Equity or its related term are showing as below:
XSWX:VBSN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.63 Med: 12.08 Max: 16.94
Current: 12.23
During the past 13 years, IVF hartmann Holding AG's highest Return-on-Tangible-Equity was 16.94%. The lowest was 4.63%. And the median was 12.08%.
XSWX:VBSN's Return-on-Tangible-Equity is ranked better than 71.58% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 4.03
vs XSWX:VBSN: 12.23
IVF hartmann Holding AG (XSWX:VBSN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
IVF hartmann Holding AG Return-on-Tangible-Equity Related Terms
IVF hartmann Holding AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for IVF hartmann Holding AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG Return-on-Tangible-Equity Chart
XSWX:VBSN vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.48% mean?
IVF hartmann Holding AG (XSWX:VBSN) has a Return-on-Tangible-Equity of 13.48% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on IVF hartmann Holding AG and its competitors. This is 12% above median its historical median of 12.08. Over the past decade, IVF hartmann Holding AG's Return-on-Tangible-Equity has ranged from 4.63 to 16.94. According to the industry distribution chart, IVF hartmann Holding AG ranks #216 out of 760 companies in the Medical Devices & Instruments industry, placing it in the top 28.4%.
Is IVF hartmann Holding AG's Return-on-Tangible-Equity too high?
IVF hartmann Holding AG's current Return-on-Tangible-Equity of 13.48% is 12% above median its 10-year median of 12.08. Over the past 10 years, this metric has ranged from a low of 4.63 to a high of 16.94. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.03. IVF hartmann Holding AG's value of 13.48% is 234.5% above this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #216 out of 760 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #216 out of 760 companies for Return-on-Tangible-Equity. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.03. IVF hartmann Holding AG's value of 13.48% is 234.5% above this benchmark. Historically, IVF hartmann Holding AG's own Return-on-Tangible-Equity has ranged from 4.63 to 16.94 over the past decade. While the company's 10-year median is 12.08 vs. the industry median of 4.03, IVF hartmann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.03, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current Return-on-Tangible-Equity of 13.48% is 234.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Return-on-Tangible-Equity is 13.48%, which is 12% above median its own 10-year median of 12.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.27, compared to a current price of CHF132.00 — trading 7.9% below its estimated fair value. The current Return-on-Tangible-Equity is 13.48%, which is 12% above median its 10-year median of 12.08 and 234.5% above the Medical Devices & Instruments industry median of 4.03. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Return-on-Tangible-Equity is 13.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF132.00 is trading 7.9% below its estimated GF Value™ of CHF143.27.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
Return-on-Tangible-Equity: 13.48% (12% above median its 10-year median of 12.08)
GF Value™: CHF143.27 vs. price of CHF132.00 (7.9% below fair value)
Industry Position: 234.5% above the Medical Devices & Instruments median (#216 of 760)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
